QQ客服 官方微博 反馈留言

	Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients
	Wang, Lei-Yun; Cui, Jia-Jia; Guo, Ao-Xiang; Yin, Ji-Ye*
刊名	OncoTargets and Therapy
	2018
卷号	11页码:529-538
关键词	Chinese patients NSCLC afatinib companion diagnosis drug resistance side effect
ISSN号	1178-6930
DOI	10.2147/OTT.S136579
URL标识	查看原文
WOS记录号	WOS:000423544200001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3343448
专题	中南大学
作者单位	1.[Yin, Ji-Ye 2.Cui, Jia-Jia 3.Guo, Ao-Xiang 4.Wang, Lei-Yun] Cent S Univ, XiangYa Hosp, Dept Clin Pharmacol, 110 XiangYa Rd, Changsha 410008, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Wang, Lei-Yun,Cui, Jia-Jia,Guo, Ao-Xiang,et al. Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients[J]. OncoTargets and Therapy,2018,11:529-538.
APA	Wang, Lei-Yun,Cui, Jia-Jia,Guo, Ao-Xiang,&Yin, Ji-Ye*.(2018).Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients.OncoTargets and Therapy,11,529-538.
MLA	Wang, Lei-Yun,et al."Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients".OncoTargets and Therapy 11(2018):529-538.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。